We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Herpes Virus Mimics Host Defense Proteins

By Biotechdaily staff writers
Posted on 29 Aug 2002
A study has found that complement plays a key role in host defense against gamma-herpes virus (gHV) infection, and that gamma-herpes viruses have evolved an immune evasion strategy that is effective against complement-mediated antiviral responses during acute but not latent infection. More...
The study was published in the August 2002 issue of Immunology.

Healthy cells produce molecules known as regulators of complement activation (RCA) to prevent inadvertent triggering of the complement system. In the current study, researchers from Washington University School of Medicine (St. Louis, MO, USA; www.wustl.edu) used a genetically engineered strain of mouse gamma-herpes virus 68 (gHV68) which lacked a protein that mimics mouse RCA protein. They compared the effects of the normal RCA-containing virus and the mutant virus on normal mice versus mice that lacked a key complement protein, C3.

The virus strain lacking the RCA mimic protein was far less virulent than the normal virus. About 100 times more of the mutant virus was required to infect healthy mice than was the normal virus. The mutant virus grew 27 times slower than the normal strain and failed to spread to other organs during acute infection. When the genetically engineered virus was injected into mice lacking C3, it was just as virulent as the normal viruses are in normal mice, since the virus did not need to disguise itself with RCA in order to thrive.

The researchers found that while healthy mice infected with gHV68 rarely showed signs of persistent infection, this condition readily occurred in C3-deficient mice. Furthermore, during latent infections three to five times more virus could be reactivated in C3-deficient mice than in normal mice.

"These findings reveal another molecular mechanism by which viruses evade the immune system,” said study leader Dr. Herbert W. Virgin, professor of pathology and immunology and molecular microbiology at Washington University. "Our findings explicitly show that complement plays a role during persistent and latent infection, and that was unexpected. They also emphasize that we cannot study a viral protein during just one part of a virus's life cycle and assume we understand the function of that protein. It is important to look at it during all phases of infection.”



Related Links:
Washington University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
HPV Test
Allplex HPV28 Detection
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.